Nootropil: Advanced Cognitive Support for Enhanced Mental Performance
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.10 | $66.20 (0%) | 🛒 Add to cart |
| 90 | $1.07 | $99.31 $96.30 (3%) | 🛒 Add to cart |
| 120 | $1.04 | $132.41 $125.39 (5%) | 🛒 Add to cart |
| 180 | $1.03 | $198.61 $184.57 (7%) | 🛒 Add to cart |
| 270 | $1.01 | $297.92 $273.85 (8%) | 🛒 Add to cart |
| 360 | $1.01
Best per pill | $397.23 $364.13 (8%) | 🛒 Add to cart |
Synonyms
| |||
Nootropil is a clinically established nootropic agent, with the active ingredient piracetam, designed to support and enhance cognitive function. It is widely utilized in medical practice for its neuromodulatory and neuroprotective properties, acting on neuronal and vascular functions to improve mental performance under various conditions. This product is indicated for use in managing cognitive deficits and is recognized for its favorable safety profile when administered under professional guidance.
Features
- Active ingredient: Piracetam 800mg or 1200mg per tablet
- Pharmaceutical form: Film-coated tablets for oral administration
- Mechanism of action: Modulates neurotransmission, enhances neuronal plasticity, and improves cerebral microcirculation
- High bioavailability and rapid absorption following oral intake
- Manufactured under strict GMP (Good Manufacturing Practice) standards
- Prescription-only medication in most jurisdictions
Benefits
- Enhances learning capacity and memory consolidation in cognitive impairment
- Supports recovery of cognitive function following cerebral insults
- Improves neuronal metabolism and oxygen utilization in the brain
- May aid in the management of cortical myoclonus
- Promotes neuroprotective effects under hypoxic conditions
- Facilitates interhemispheric transfer of information
Common use
Nootropil is primarily indicated for the adjunctive treatment of cortical myoclonus. It is also used off-label in various cognitive disorders, including those associated with aging, post-stroke recovery, and other conditions involving cognitive decline. Its application extends to supportive therapy in dyslexia and sickle cell anemia-related complications in some regions, based on regional licensing.
Dosage and direction
The dosage of Nootropil must be individualized based on the patient’s condition, renal function, and therapeutic response. For cortical myoclonus, initial doses typically range from 7.2g/day up to 24g/day, divided into 2–3 doses. Maintenance doses are adjusted accordingly. Tablets should be taken with liquid, with or without food, though consistent administration relative to meals is advised. Dosage should be reduced in patients with renal impairment.
Precautions
Patients with renal impairment require dose adjustment and careful monitoring. Hemostasis parameters should be monitored in surgical patients due to potential effects on platelet aggregation. Use with caution in patients with a history of hemorrhagic diathesis. Discontinuation should be gradual to avoid withdrawal symptoms. Not recommended during pregnancy or lactation unless clearly needed.
Contraindications
Nootropil is contraindicated in patients with known hypersensitivity to piracetam or any excipients in the formulation. It is also contraindicated in those with severe renal impairment (creatinine clearance <20 mL/min) and patients with cerebral hemorrhage. Should not be used in individuals with Huntington’s chorea due to possible exacerbation of symptoms.
Possible side effects
Common side effects include nervousness, weight gain, drowsiness, depression, and asthenia. Gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain may occur. Less frequently, hyperkinesia, ataxia, confusion, and dizziness have been reported. Severe side effects are rare but may include severe dermatological reactions, angioedema, or anaphylaxis.
Drug interaction
Nootropil may potentiate the effects of anticoagulants and antiplatelet drugs, increasing the risk of bleeding. Concurrent use with thyroid hormone extracts may cause confusion, irritability, and sleep disturbances. Caution is advised when co-administering with other CNS-active drugs due to additive effects. No significant interactions with hepatic enzyme inducers or inhibitors have been conclusively established.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Consistent adherence to the prescribed regimen is important for optimal therapeutic outcomes.
Overdose
Symptoms of overdose may include severe diarrhea, abdominal pain, and marked lethargy. In cases of significant overdose, gastric lavage and symptomatic treatment are recommended. Hemodialysis may be effective due to piracetam’s low protein binding and renal excretion. There is no specific antidote; management should focus on supportive care.
Storage
Store in the original container at room temperature (15–30°C), protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Proper storage ensures stability and efficacy throughout the product’s shelf life.
Disclaimer
This information is intended for medical professionals and should not replace personalized medical advice. Always consult a healthcare provider for diagnosis, treatment options, and dosing tailored to individual patient needs. The prescriber should be aware of regional variations in approved indications and legal status.
Reviews
Clinical studies and meta-analyses have demonstrated Nootropil’s efficacy in improving cognitive metrics in vascular and degenerative cognitive disorders. Expert consensus supports its use in specific neurological conditions, particularly cortical myoclonus. Patient-reported outcomes often note subjective improvements in memory, focus, and overall cognitive endurance, though individual responses may vary. Long-term safety data are robust, contributing to its enduring use in neurological therapeutics.